Alcon raises STAAR Surgical acquisition price to $30.75 per share from $28.00

STAAR SURGICAL CO

Merger consideration increased to $30.75/share in cash, up from $28.00/share (approx. 9.8% increase).
Amendment treats RSUs and PSUs as Alcon equity awards; PSUs deemed earned at 100% of target.
Amendment eliminates 280G gross-up and related tax indemnification arrangements.
Deal requires stockholder approval and regulatory clearances; proxy statement filed September 16, 2025.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.